 ThirdAge |
Dendreon Gets FDA Approval To Expand Provenge Production
Wall Street Journal NEW YORK (Dow Jones)–Dendreon Corp. (DNDN) received US Food and Drug Administration approval to quadruple the production capacity of supply-constrained prostate-cancer drug Provenge at its New Jersey … Dendreon Given FDA Approval To Expand Cancer Drug Production Dendreon gets OK to quadruple cancer drug's output Dendreon gets FDA OK to expand Provenge capacity |
View full post on Health – Google News
